Price
CHART BY
Frequently asked questions
What is Legend Biotech 2 Adr Rep's market capitalization?
The market capitalization of Legend Biotech 2 Adr Rep is $5.85B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Legend Biotech 2 Adr Rep?
Legend Biotech 2 Adr Rep's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.774. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Legend Biotech 2 Adr Rep's stock?
Currently, 19 analysts cover Legend Biotech 2 Adr Rep's stock, with a consensus target price of $74.58. Analyst ratings provide insights into the stock's expected performance.
What is Legend Biotech 2 Adr Rep's revenue over the trailing twelve months?
Over the trailing twelve months, Legend Biotech 2 Adr Rep reported a revenue of $797.34M.
What is the EBITDA for Legend Biotech 2 Adr Rep?
Legend Biotech 2 Adr Rep's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$198.81M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Legend Biotech 2 Adr Rep?
Legend Biotech 2 Adr Rep has a free cash flow of -$332.79M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Legend Biotech 2 Adr Rep have, and what sector and industry does it belong to?
Legend Biotech 2 Adr Rep employs approximately 2,609 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Legend Biotech 2 Adr Rep's shares?
The free float of Legend Biotech 2 Adr Rep is 180.77M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $5.85B
- EPS (TTM)
- -$1.774
- Free Float
- 180.77M
- Revenue (TTM)
- $797.34M
- EBITDA (TTM)
- -$198.81M
- Free Cashflow (TTM)
- -$332.79M
Pricing
- 1D span
- $31.61$32.45
- 52W span
- $27.35$47.63
Analyst Ratings
The price target is $74.58 and the stock is covered by 19 analysts.
Buy
18
Hold
1
Sell
0
Information
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
- Employees
- 2,609
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- LEGN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet